pharmaphorum

OCTOBER 26, 2022

Anyone who watches television has heard the list of potential adverse reactions, considering that commercials for psoriasis treatments are seemingly only outnumbered by goofy ads for auto insurance. For milder cases, doctors have traditionally prescribed topical corticosteroids, vitamin D analogues, and retinoids.

Immunization 98

Immunization Adverse Reactions Insurance FDA 98

PharmaShots

JUNE 23, 2023

Shots: Cassiopea will receive an up front & is also eligible to receive regulatory and sales milestones along with royalties on net sales Hyundai Pharm to get an exclusive right to register and commercialize Winlevi in the Republic of Korea while Cosmo will be the exclusive supplier of the product.

40

40

Fuld

NOVEMBER 29, 2022

Used a customized schedule of monthly topics to report on a quarterly basis to give the client flexibility based on the dynamics of the market. ?. With this information, the client could make better decisions about its own clinical trial design, development timelines, and commercial planning. Our Solution.

Vaccines 52

Vaccines 52

ISPE

FEBRUARY 6, 2023

Wuxi Biologics, Shanghai Sen Lan WaiGaoqiao Commercial Operation Center Co., This summit ISPE joined with two co-organizers, four sponsors, 39 industry experts, and nearly 1,000 participants in this wonderful academic information sharing. Let’s review the exciting content of the conference together! Glaser Life Sciences (Shanghai) Co.,

Communication 98

Communication 98

PharmaShots

JANUARY 23, 2023

Until recently, there were very few topical options available for treating plaque psoriasis long-term. Typically, some patients start with topical steroids; however, these can be challenging, as many are limited by where they can be applied on the body and for how long and how often they can be used. [i] of VTAMA cream?

FDA 40

FDA Labelling Immunization 40

Pharmaceutical Technology

DECEMBER 5, 2022

According to the deal, Incyte is entitled to receive an upfront payment from CMS, which will also make further potential payments on meeting development, regulatory and commercial milestones. Ruxolitinib cream is the first topical inhibitor of JAK to obtain approval in the US.

FDA 52

FDA 52

Viseven

OCTOBER 3, 2023

On September 11, Viseven was in Singapore to visit magnificent Marina Bay Sands resort and take part in Veeva APAC Commercial Summit 2023 as one of the silver sponsors. This year’s APAC Commercial Summit was no exception. The post Viseven Attends Veeva APAC Commercial Summit 2023 appeared first on Viseven.

52

52

PharmaShots

MARCH 30, 2023

Equity investment into Galimedix supports Galimedix's pipeline development TOI gets an exclusive right to develop & commercialize Galimedix’s GAL-101 for topical & oral treatment of dry AMD, glaucoma & other ophthalmic indications in the EU, the Americas, the Middle East & Africa.

40

40

Pharmaceutical Technology

MARCH 3, 2023

With over 18 years of experience, Alexander Dragitsch is a commercial customer service contract manufacturing (CSCM) manager at Baxter’s Halle/Westfalen facility in Germany. Alex and his team have the significant responsibility of managing various commercial programs for more than 40 marketed products.

Customer Service 52

Customer Service Documentation 52

pharmaphorum

MAY 25, 2022

Roivant group company Dermavant has made the transition to a commercial-stage company after getting FDA approval for Vtama, a drug for psoriasis that it claims could be a game-changer in the treatment of the skin disorder. Otezla – which Amgen acquired for $13.4

FDA 52

FDA Labelling 52

Pharmaceutical Technology

MAY 17, 2023

AGC Biologics has introduced the BravoAAV and ProntoLVV viral vector platforms that offer quick clinical and commercial production and release of good manufacturing practices (GMP). Topic sponsors are not involved in the creation of editorial content. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

52

52

The FDA Law Blog

APRIL 21, 2024

which brings us to the topic of this post. Rather, “permission for commercial marketing” was only effective upon FDA’s issuance of its corrected October 5, 2022 letter. On occasion, PTE applicants try to fight a PTO determination that the application was untimely. Taiho Pharmaceutical Co., sections 331(a) and 352.(a)(l),

Labelling 59

Labelling FDA Controlled Substances 59

Pharmaceutical Technology

JUNE 9, 2023

The US Food and Drug Administration (FDA) has granted approval to commence commercial production at Bristol Myers Squibb’s new advanced cell therapy manufacturing facility in Devens, Massachusetts. The site has been involved in the development, manufacture and testing of clinical and commercial medicines.

FDA 52

FDA 52

pharmaphorum

SEPTEMBER 28, 2021

Watch the video below to hear more on those topics and to find out more about Sidekick Health, its solution and partnerships, plus Sam’s personal advice for budding entrepreneurs. About the interviewee. Prior to this, he founded pharmaphorum in 2009, which was acquired by Healthware Group in June 2020.

Communication 94

Communication Hospitals 94

Pharmaceutical Technology

OCTOBER 25, 2022

To aid Taysha in using the gene therapy clinical and commercial capabilities of Astellas for TSHA-120 and TSHA-102 development, Astellas will receive a board observer seat on Taysha’s directors’ board. Topic sponsors are not involved in the creation of editorial content.

105

105

pharmaphorum

OCTOBER 28, 2022

Nina Pinwill BSc (Hons) MSc DIC, is the Head of Commercial Operations at NHS England and NHS Improvement. Nina Pinwill leads the commercial operations function within the Commercial Medicines Directorate at NHS England. She is an SME in market access, rare disease and biosimilars.

120

120

PharmaShots

FEBRUARY 10, 2023

The results from (DELTA 2) trial will be planned to submit for scientific presentation and publication LEO & Japan Tobacco collaborated in 2014 in which LEO gained exclusive rights to develop & commercialize delgocitinib for topical use in dermatological indications globally & JT retains rights in Japan Ref: Businesswire | Image: LEO Pharma (..)

FDA 40

FDA 40

Pharmaceutical Technology

NOVEMBER 16, 2022

A custom-made viral vector and cell therapy centre of excellence, ElevateBio BaseCamp has an end-to-end process development and existing Good Manufacturing Practice (cGMP) production expertise for research, clinical and commercial cell and gene therapies and regenerative treatments.

Immunization 98

Immunization 98

BuzzRx

OCTOBER 14, 2022

In other words, while most pharmacies simply dispense pre-made medications, compounding pharmacies make customized medications that are not available from commercial drug manufacturers. Pharmaceutical compounding helps to meet the needs of an individual patient that can’t be met by commercially available medications.

Compounding Pharmacies 52

Compounding Pharmacies Compounding Dosage Sterile Compounds 52

ISPE

MARCH 22, 2023

The number of novel drugs progressing from clinical to commercial scale is increasing as can be seen from the number of novel drugs approved by the FDA in 2022 alone. The conference is expected to attract delegates from across the globe and promises very engaging and informative discussions and networking sessions.

FDA 98

FDA 98

Pharmaceutical Technology

JANUARY 5, 2023

Capsida Biotherapeutics CEO Peter Anastasiou said: “Prevail’s expertise in neuroscience, gene therapy R&D, and access to Lilly’s world-class commercialization capabilities complements Capsida’s fully integrated approach, including our next-generation AAV engineering platform. Free Whitepaper.

Communication 95

Communication 95

pharmaphorum

AUGUST 17, 2021

Watch the video below to hear more on those topics and to find out more about PureTech’s interest in digital health, how that lines up alongside its focus on medicines, and some of the biotech company’s key partnerships. They also delve into PureTech’s pioneering ‘hub and spoke’ business model and how it is becoming increasingly popular.

Communication 110

Communication Immunization 110

Pharmaceutical Technology

JUNE 12, 2023

Patients with erectile dysfunction (ED) will now be able to access a topical treatment without the need for a prescription after the US Food and Drug Administration (FDA) greenlit Futura Medical’s Eroxon. The addition of a topical gel to pharmacy shelves expands treatment options available to those with ED.

FDA 52

FDA 52

pharmaphorum

AUGUST 28, 2020

Italian biotech Cassiopea has won US approval for Winlevi, a topical therapy it says is the first new approach to treating acne in nearly 40 years.

FDA 52

FDA Immunization 52

Pharma Marketing Network

APRIL 5, 2023

The event included a focus on Medical Affairs, as a reflection of industry moving away from a ‘church and state’ approach to medical and commercial. We also saw the addition of a track focused on Cell and Gene Therapy, as Pharma ventures into the commercialization of therapeutics. A more ‘systematized’ approach to insights.

52

52

Pharmaceutical Technology

MAY 24, 2023

The BGTC aims to expedite the development, manufacture and delivery of customised or “bespoke” gene therapies to treat rare diseases, including some which are too rare to be of commercial interest. Topic sponsors are not involved in the creation of editorial content.

FDA 96

FDA 96

pharmaphorum

AUGUST 22, 2022

Among the infinite symposia, webinars, and white papers on this topic,?“KOL KOL identification is the process of identifying those individuals with high levels of expertise and influence in a given therapeutic area; in the context of building your medical and commercial strategy.? Robert Hollands. e: robert.hollands@vmlyr.com.

52

52

The Checkup by Singlecare

NOVEMBER 10, 2022

Most of the clips highlight users applying either honey or garlic topically. In other videos, users can be seen eating honey and garlic for acne relief, instead of applying it topically—some even chug the amber liquid straight out of the bottle or chow down on raw peeled garlic.

Medication Guidelines 98

Medication Guidelines Hospitals 98

Pharmaceutical Technology

AUGUST 28, 2022

Additionally, it expected firms such as Pfizer and BioNTech to respect its intellectual property rights and considered granting them a commercially reasonable licence, if they sought one for other markets. Topic sponsors are not involved in the creation of editorial content.

Vaccines 98

Vaccines 98

pharmaphorum

MARCH 15, 2022

Having a strategy that acknowledges and addresses barriers to engagement will help clinical, medical affairs, and commercial teams create meaningful opportunities for patients that yield deeper, more actionable insights. Deep Dive Magazine – In-depth looks at the most important topics facing the industry.

98

98

Pharmaceutical Technology

MARCH 29, 2023

The companies will co-fund research and development for all products and split the future commercial expenses and profits equally. Topic sponsors are not involved in the creation of editorial content. Sonoma will also be eligible to receive a development milestone payment of $45m.

98

98

pharmaphorum

AUGUST 31, 2022

Futura Medical’s development of a topical treatment for erectile dysfunction (ED) is approaching the finish line in the US, as the UK biotech reports confirmatory phase 3 data ahead of an FDA filing later this month. ” The post Futura eyes FDA filing as topical ED drug passes phase 3 test appeared first on.

FDA 52

FDA 52

Pharmaceutical Technology

MAY 4, 2023

Topic sponsors are not involved in the creation of editorial content. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Editorial content is independently produced and follows the highest standards of journalistic integrity.

102

102

pharmaphorum

NOVEMBER 3, 2022

With pharmaphorum once more in attendance, expect coverage of an ever wide and ranging spectrum of topics, all united by the shared goal of seeking sustainable change for Britain, whilst bearing in mind her role upon the global stage at this critical juncture in history.

87

87

The FDA Law Blog

MARCH 6, 2024

The American Conference Institute (“ACI”) will be hosting a series of go-to forums on critical topics including novel therapeutics, cosmetics/personal care products and Paragraph IV disputes. He’ll be speaking on “Bridging the Gap: From Pre-Commercialization Research to Regulatory Approval for Novel Therapeutics and Regenerative Medicines.”

FDA 59

FDA Pharmaceutical Companies Pharmaceutical Companies 59

Pharmaceutical Technology

FEBRUARY 13, 2023

This trial assessed Cibinqo 100mg and 200mg doses against placebo in moderate-to-severe AD adolescents aged 12 to less than 18 years who were on background treatment with topical medications.

FDA 59

FDA Labelling 59

Pharmaceutical Technology

AUGUST 17, 2022

It will also have the potential to scale to Phase III clinical development and commercial manufacturing. RoosterBio CEO Tim Kelly said: “AGC Biologics has an outstanding track record of success in the manufacture of clinical and commercial advanced therapies and an ever-expanding global network to meet the needs of our customers.

Vaccines 52

Vaccines 52